Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07817641
NA
Proton Therapy for Mediastinal Lymphoma (PROMLY)
Sponsor: Rigshospitalet, Denmark
View on ClinicalTrials.gov
Summary
The study aims to investigate whether proton therapy is feasible in a national setting and whether proton therapy can reduce the risk of late toxicity (secondary cancers and heart toxicity) compared to foton therapy.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
139
Start Date
2026-05-01
Completion Date
2046-05-01
Last Updated
2026-09-14
Healthy Volunteers
No
Interventions
RADIATION
Proton therapy
If selected, patients will recieve protontherapy instead of photon therapy
Locations (1)
Dept. of oncology
Copenhagen, Select A State, Denmark